First-line thalidomide-dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

Abderrahman Abdelkefi,Lamia Torjman,N. Ben Romdhane,Saloua Ladeb,H. El Omri,T Ben-Othman,Moez Elloumi,Hatem Bellaj,Amel Lakhal,R. Jeddi,Lamia Aissaoui,Ali Saad,Hsaïri M,K. Boukef,Koussay Dellagi,A. Ben Abdeladhim

First-line thalidomide-dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

2005

Abderrahman Abdelkefi
Lamia Torjman
N. Ben Romdhane
Saloua Ladeb
H. El Omri
T Ben-Othman
Moez Elloumi
Hatem Bellaj
Amel Lakhal
R. Jeddi
Lamia Aissaoui
Ali Saad
Hsaïri M
K. Boukef
Koussay Dellagi
A. Ben Abdeladhim

First-line thalidomide–dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

Keywords:

Immunology
Stem cell
Dexamethasone
Hematology
Thalidomide
Autologous stem-cell transplantation
Medicine
Internal medicine
Multiple myeloma
Corticosteroid
antibacterial agent

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations